Detailed Notes on cgmp manufacturing
No. 21 CFR 211.113(a) requires acceptable composed methods to be established and followed for the duration of manufacturing to prevent objectionable microorganisms in drug solutions not required to be sterile. Additionally, the second paragraph of USP Common Chapter Antimicrobial Efficiency Tests reads: Antimicrobial preservatives shouldn'